Medicamentos de Malasia


Medicamentos que empiezan por tA

Elija la segunda letra del medicamento:

Malasia
TAGAMET tablet 200 mg
GlaxoSmithKline Pharmaceutical SDN BHD
Malasia
TAGATAI ointment 10%
Malaysian Pharmaceutical Industries SDN. BHD
Malasia
TAGREN tablet 250 mg
Pahang Pharmacy SDN. BHD
Malasia
TAISHO KAMPO tablet
DKSH Malaysia SDN BHD
Malasia
TAMBOCOR tablet 100 mg
iNova Pharmaceuticals Pte Ltd Malaysia Branch
Malasia
TAMIFLU capsule, hard 75 mg
Roche (Malaysia) SDN BHD
Malasia
TAMOPLEX tablet 10 mg
United Italian Trading (M) SDN BHD
Malasia
TAMOPLEX tablet 20 mg
United Italian Trading (M) SDN BHD
Malasia
TAMOXIFEN EBEWE tablet 20 mg
Luen Wah Medical Company SDN BHD
Malasia
TANATRIL tablet 10 mg
Mitsubishi Tanabe Pharma Corp
Malasia
TANATRIL tablet 5 mg
Mitsubishi Tanabe Pharma Corp
Malasia
TANCOFETO powder for solution for infusion 1 g
GlaxoSmithKline Pharmaceutical SDN BHD
Malasia
TANCOFETO powder for solution for infusion 500 mg
GlaxoSmithKline Pharmaceutical SDN BHD
Malasia
TANZARIL film-coated tablet 50 mg
Milrin Pharmaceutical Co. (M) SDN BHD
Malasia
TARATEN cream 1%
Luen Wah Medical Company SDN BHD
Malasia
TARCEVA film-coated tablet 100 mg
Roche (Malaysia) SDN BHD
Malasia
TARCEVA film-coated tablet 150 mg
Roche (Malaysia) SDN BHD
Malasia
TARCEVA film-coated tablet 25 mg
Roche (Malaysia) SDN BHD
Malasia
TARGET tablet 100 mg+25 mg
The Zyfas Medical Co.
Malasia
TARGIN prolonged-release tablet 10 mg+5 mg
Mundipharma Pharmaceuticals SDN BHD
Malasia
TARGIN prolonged-release tablet 20 mg+10 mg
Mundipharma Pharmaceuticals SDN BHD
Malasia
TARGIN prolonged-release tablet 40 mg+20 mg
Mundipharma Pharmaceuticals SDN BHD
Malasia
TARGIN prolonged-release tablet 5 mg+2.5 mg
Mundipharma Pharmaceuticals SDN BHD
Malasia
TASIGNA capsule, hard 200 mg
Novartis Corporation (M) Sdn Bhd
Malasia
TAVER tablet 200 mg
Komedic SDN BHD
Malasia
TAVETINE tablet 1 mg
Duopharma (M) SDN. BHD
Malasia
TAXOL concentrate for solution for infusion 30 mg/5 ml
Bristol-Myers Squibb (Malaysia)Sdn Bhd
Malasia
TAZROBIDA powder for solution for injection 2 g+250 mg
GlaxoSmithKline Pharmaceutical SDN BHD